psilocybin
Phase 3- Indications
- Major Depressive Disorder
Company intelligence / Profile preview
Usona Institute
Madison, Wisconsin, United States
- Ownership
- Private
- Employees
- ~30
- Development stage
- Phase 3
01
Overview
Usona Institute is a non-profit medical research organization developing psychedelic compounds—primarily psilocybin—for the treatment of depression and related mental health conditions. Its lead program in psilocybin for major depressive disorder has completed Phase 2 and is currently in a large Phase 3 trial. The institute also develops other tryptamine-based psychedelics such as mebufotenin and bufotenin, with early-stage programs exploring new chemical entities inspired by natural products. Usona received FDA Breakthrough Therapy Designation for its psilocybin program in MDD[1][7]. The organization is notable for supplying synthetic psilocybin free of charge to global researchers.
- Therapeutic areas
- Psychiatry
- Modalities
- Small moleculePsychedelic compoundSynthetic small molecule (for psilocybin, 5-MeO-DMT, bufotenin, etc.)
- Industry
- Academic Hospital/University/Research
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
National Institute on Drug Abuse Intramural Research Program [8]National Institute of Mental Health's Psychoactive Drug Screening Program [8]Academic collaborations globally [6][2]
Beyond the preview
Go deeper on Usona Institute.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Usona Institute.